Skip to main content

LIVE CORONAVIRUS UPDATES: Inside New York's hospitals, Pfizer starts human vaccine trials

Donald Trump coronavirus task forceAlex Wong/Getty Images

We'll keep this page updated with the biggest coronavirus headlines of the day. Scroll down for more information on each story and check back for updates.

Here's the latest:

  • 'Unpredictable': NYC's doctors share lessons from the toughest month at the epicenter of the coronavirus pandemic.
  • A leading potential coronavirus vaccine just started human trials in the US. The top scientist at Pfizer told us it could be ready for emergency use this fall.
  • A model cited repeatedly by the White House almost doubled its predicted US deaths to 134,000 by mid-August because of 'premature relaxation of social distancing.'
  • The White House has banned its entire coronavirus task force from testifying to Congress, as a House panel gears up to investigate the government's pandemic response.
  • A Family Dollar security guard was shot dead after trying to enforce Michigan's compulsory face mask law.
  • Canada is dealing with the coronavirus far better than the US, which has 30% more deaths per capita. Here's why.
  • Israel's government research agency says it successfully isolated a key coronavirus antibody, paving the way for a possible breakthrough treatment.
  • Scott Galloway predicts Amazon will be the fastest growing healthcare company by 2025, many US universities may never reopen, and says the best time to start a new business is in the depths of a recession.
  • Intel from US allies suggest it is 'highly unlikely' the coronavirus came from a Chinese lab and 'highly likely' that it was 'naturally occurring.'
  • Fauci yet again dismisses conspiracy theory that the coronavirus was made in a Wuhan lab after Pompeo touted 'enormous evidence' of a cover up.

Visit Business Insider's homepage for more stories.

Data Ticker - Covid 19 Global and US

'Unpredictable': NYC's doctors share lessons from the toughest month at the epicenter of the coronavirus pandemic.

New York City's hospitals were slammed in April by the peak of the coronavirus pandemic.

Along the way, doctors there learned a lot more about the disease, making decisions that can help prevent additional deaths.

As the surge of new patients starts to slow, the city is grappling with what's ahead, as surgeries start to resume and emergency rooms empty out.

Read more



A leading potential coronavirus vaccine just started human trials in the US. The top scientist at Pfizer told us it could be ready for emergency use this fall.

Pfizer and BioNTech have started testing their coronavirus vaccine candidates in healthy volunteers in the US.

Mikael Dolsten, Pfizer's chief scientific officer, told Business Insider this experimental vaccine could be ready for emergency use this fall.

"I don't think this has ever happened in the history of modern vaccines," Dolsten said of the speedy timeline.

The US trials are testing four variations of a coronavirus vaccine developed by the pharma giant Pfizer and its smaller biotech partner BioNTech.

Dolsten outlined how a vaccine candidate could be tested in real-time during a subsequent outbreak of COVID-19 this fall.

Read more



A model cited repeatedly by the White House almost doubled its predicted US deaths to 134,000 by mid-August because of 'premature relaxation of social distancing.'

An influential model of how the coronavirus will hit the US has almost doubled the number of deaths it predicts will take place by mid-August, raising it to 134,000 people.

The University of Washington's Institute for Health Metrics and Evaluation raised its estimate sharply — last week it was around 72,000.

The institute partly attributed the higher estimate to widespread plans to lift state-level lockdowns this week.

The IHME model has been used by the White House, which has also been revising its estimated death toll upwards.

So far more than 68,000 people have died from the virus in the US.

Read more




See the rest of the story at Business Insider

See Also:

Comments

Post a Comment

Popular posts from this blog

Narratives about modernity

If we give an isolated community access to the internet, very quickly, the quality of life will improve. Time will be saved, research into proven solutions will produce value, and people will become connected to a larger population. Those connections will lead to productivity and learning. And, then, soon thereafter, they will become less happy. Not because they’re worse off, but because the dominant media narratives that arrive exist to make them feel insufficient, inadequate or simply jealous at how green the grass is over there. Our narrative defeats our surroundings, every time.
Post a Comment
Read more

You’ll never guess Airbnb’s hottest destination for 2020. Really.

Here’s a hint: It’s in the U.S. Planning a trip in the next year? Airbnb has released its hottest destinations for 2020 —a list of cities, countries, and states across the globe that are seeing the largest year-over-year percentage growth in bookings. Of course there are gems you would expect: Hundreds of miles of palm-lined beaches in Kerala, India (which saw a 95% YOY increase), for instance, or the European cultural hot spot Bilbao, Spain (which saw a 402% YOY increase). Read Full Story
Post a Comment
Read more

Experts tell us how coronavirus will weaken China's position as a global trade partner — and endanger its phase-one deal with the US

Kevin Lamarque/Reuters The coronavirus is jeopardizing China's ability to meet obligations it agreed to as part of the phase-one trade deal with the US. China pledged to buy an extra $200 billion worth of US goods over the next two years, but the outbreak is harming the country's purchasing power and demand for numerous imports, according to Stephen Roach, senior lecturer at the Yale School of Management. The pandemic also delays the face-to-face meetings needed to coordinate such large purchases, said Mary Lovely, an economics professor at Syracuse University. Chinese officials could ask the US for leniency in enforcing the deal's timeline, but "we have no idea" how the Trump administration may respond, Lovely noted. Visit the Business Insider homepage for more stories . The rapidly spreading coronavirus may have a new victim: the US-China trade agreement. The virus has already wreaked havoc throughout China. Its death toll surpassed 360 people as of ea...
Post a Comment
Read more